Virtuvax

Over Virtuvax

Virtuvax provides essential guidance for development of vaccines and biologics from preclinical until marketing. Our key strengths include:

Strategy design Design of a development strategy with the end-point in mind: a target product profile (TPP) plus Quality-TPP (QTPP) following the principles of Quality by Design (QbD) as part of an integrated development plan (IDP) including milestones, objectives, risk assessment/alternative development options and delivery on time / budget. Pre-clinical, Chemistry, Manufacturing and Controls (CMC) and clinical Drug Development - Non-clinical development program: pre-clinical efficacy and safety study design and execution, preclinical assay design - Biomarker development: assay design, standardization and analytical validation in accordance with ICH guidelines; test development in accordance with medical device regulations - Design of product development plan - Clinical studies: (assistance in) design and scientific writing of IMPD/IND; Pharmacovigilance: design and evaluation of phase IV clinical, CRO management Life cycle management - Technology transfer: product/technology evaluation, feasibility study design, gap assessment and risk management, design of in-licencing / out-licensing contracts and transfer package General expertises for interim assignments in life sciences requiring - Line management - Vendor management - Project management - Business development

Trefwoorden

• Business Development
• Consultancy
• Executive Management
• Vaccine Development
• Vaccine Technology

Adres

• Hoofdkantoor

  IJsvogelwaardOdijkUtrecht, Nederland

Team per functiegebied

Gebaseerd op 1 openbare functieprofielen, stand van 3 september 2026.

• Executive / C-Suite1